Study of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis
Public ClinicalTrials.gov record NCT02029495. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis: AMVISION-1
Study identification
- NCT ID
- NCT02029495
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Bausch Health Americas, Inc.
- Industry
- Enrollment
- 478 participants
Conditions and interventions
Conditions
Interventions
- 140 mg brodalumab Drug
- 210 mg brodalumab Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2014
- Primary completion
- Sep 30, 2015
- Completion
- Sep 30, 2015
- Last update posted
- May 18, 2017
2014 – 2015
United States locations
- U.S. sites
- 43
- U.S. states
- 25
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Huntsville | Alabama | 35801 | — |
| Research Site | Tuscaloosa | Alabama | 35406 | — |
| Research Site | Peoria | Arizona | 85381 | — |
| Research Site | Scottsdale | Arizona | 85258 | — |
| Research Site | Los Angeles | California | 90095 | — |
| Research Site | Mather | California | 95655 | — |
| Research Site | Murrieta | California | 92563 | — |
| Research Site | Palm Desert | California | 92260 | — |
| Research Site | Tustin | California | 92780 | — |
| Research Site | Upland | California | 91786 | — |
| Research Site | Jupiter | Florida | 33458 | — |
| Research Site | Tamarac | Florida | 33321 | — |
| Research Site | Tampa | Florida | 33613 | — |
| Research Site | Gainesville | Georgia | 30501 | — |
| Research Site | Meridian | Idaho | 83642 | — |
| Research Site | Springfield | Illinois | 62703 | — |
| Research Site | Bowling Green | Kentucky | 42101 | — |
| Research Site | Somerset | Kentucky | 42503 | — |
| Research Site | Frederick | Maryland | 21702 | — |
| Research Site | Wheaton | Maryland | 20902 | — |
| Research Site | Worcester | Massachusetts | 01605 | — |
| Research Site | Lansing | Michigan | 48910 | — |
| Research Site | Eagan | Minnesota | 55121 | — |
| Research Site | Omaha | Nebraska | 68114 | — |
| Research Site | Clifton | New Jersey | 07012 | — |
| Research Site | Great Neck | New York | 11021 | — |
| Research Site | Lake Success | New York | 11042 | — |
| Research Site | New York | New York | 10016 | — |
| Research Site | Plainview | New York | 11803 | — |
| Research Site | Asheville | North Carolina | 28803 | — |
| Research Site | Bend | Oregon | 97701 | — |
| Research Site | Portland | Oregon | 97239 | — |
| Research Site | Duncansville | Pennsylvania | 16635 | — |
| Research Site | Charleston | South Carolina | 29406 | — |
| Research Site | Hixson | Tennessee | 37343 | — |
| Research Site | Austin | Texas | 78731 | — |
| Research Site | Houston | Texas | 77074 | — |
| Research Site | San Antonio | Texas | 78232 | — |
| Research Site | Danville | Virginia | 24541 | — |
| Research Site | Seattle | Washington | 98104 | — |
| Research Site | Beckley | West Virginia | 25801 | — |
| Research Site | Bridgeport | West Virginia | 26330 | — |
| Research Site | Glendale | Wisconsin | 53217 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 109 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02029495, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2017 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02029495 live on ClinicalTrials.gov.